中
Home
About TUL
Group Introduction
Executive Directors
Subsidiaries
Contact Us
Innovation in R&D
R&D Pipeline
R&D Platform
R&D Updates
News
TUL Highlights
Product Center
Finished Products
Comprehensive Health Products
APIs and Intermediates
Animal protection products
Empty capsule
Medical device
Cosmetic Peptide Series
Sustainability
Enhancing Governance
Normalizing Healthiness
Brand Building
People-Oriented
Green Development
ESG Reports
ESG News
Investor Relations
News
TUL Highlights
2026-09-07
UBT251 INJECTION COMPLETED FIRST PARTICIPANT DOSING IN PHASE III CLINICAL STUDY FOR OVERWEIGHT OR OBESITY IN CHINA
Learn More
2026-09-07
Significant Progress in Innovative Drug R&D and Continued Globalization Efforts Profit Attributable to Owners of the Company Reached Approximately RMB347.6 Million
Learn More
2026-08-12
FDA APPROVAL OF IND FOR THE GROUP’S PRODUCT UBT48128 TABLETS
Learn More
2026-07-15
APPROVAL FOR MARKETING OF THE GROUP’S PRODUCT SODIUM HYALURONATE EYE DROPS WITH NEW SPECIFICATION
Learn More
2026-07-03
APPROVAL FOR MARKETING OF THE GROUP’S PRODUCT TADALAFIL TABLETS
Learn More
All News
Select Year
2026
2025
2024
TUL Ranks 16th in the “2023 Top 100 Chinese Chemical Pharmaceutical Enterprises”
2024-07-30
The United Laboratories (Inner Mongolia) Co., Ltd. Receives Marketing Approval for Bulk Medicine Tazobactam
2024-06-28
TUL Delivers a Remarkable Presence at CPHI China 2024
2024-06-25
TUL Wins “ESG Responsible Enterprise Award”
2024-06-20
Chairman Tsoi Hoi Shan Attends the 90th API China and Holds Business Talks with Partners
2024-05-17
The United Laboratories (Inner Mongolia) Co., Ltd. Launches Utilization Project for Biogas Combustion Residual Heat
2024-05-13
Zhuhai United Laboratories (Zhongshan) Co., Ltd. Passes Pharmacovigilance Audit by Moldova’s Medicines and Medical Devices Agency
2024-04-29
TUL’s Insulin Products Win All Bids in Centralized Procurement Tender
2024-04-25
TUL Participates in the 19th Xiangya International Forum on Diabetes Immunology
2024-04-25
Prev
1
...
12
13
14
15
16
17
Next
WeChat
Official
Account
To Top
粤公网安备44040402000348号
